Daré Bioscience Investor Relations Material
Latest events
Q2 2025
Daré Bioscience
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Daré Bioscience Inc
Access all reports
Daré Bioscience Inc. is a biopharmaceutical company focused on developing and commercializing innovative products for women’s health. The company’s portfolio includes therapies aimed at addressing unmet needs in contraception, fertility, and sexual health. Daré’s products are designed to improve options for women by offering novel solutions in areas such as hormone-free contraception and treatments for female sexual disorders. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
DARE
Country
🇺🇸 United States